Incivek will not be available for patients after Oct. 14. While the drug will no longer be in the hepatitis C treatment market, the company has not indicated when it would stop making the drug, according to the report.
More articles on Sovaldi:
Despite price, Sovaldi still treatment of choice for Hep C
Sovaldi generates $3.48B in Q2 sales
60% of Americans Are Worried They Won’t Be Able to Afford Specialty Drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.